Pharmacogenomics, the study of how genes affect a person's response to drugs, is highly relevant in Neurocare. It allows for personalized medication plans that can improve efficacy and reduce adverse effects. For instance, variations in the CYP2D6 gene can affect how individuals metabolize certain antidepressants and antipsychotic drugs.
